A Phase 2, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome

October 25, 2018
https://clinicaltrials.gov/ct2/show/study/NCT03530293
Tourette Syndrome
Principal Investigator: Peter A Le Witt, MD
Tourette, Tourette's
Open
248-661-6540